Compare AFFY to:
After Hours: 0.00 N/A (N/A) 7:00pm ET
| Last Trade: | 21.26 |
|---|---|
| Trade Time: | Nov 25 |
| Change: | |
| Prev Close: | 21.12 |
| Open: | 21.11 |
| Bid: | 20.69 x 100 |
| Ask: | 21.96 x 100 |
| 1y Target Est: | 31.00 |
| Day's Range: | 20.98 - 21.40 |
|---|---|
| 52wk Range: | 8.52 - 25.15 |
| Volume: | 120,047 |
| Avg Vol (3m): | 160,658 |
| Market Cap: | 406.53M |
| P/E (ttm): | N/A |
| EPS (ttm): | -5.05 |
| Div & Yield: | N/A (N/A) |
| Tue, Nov 24 | Affymax Announces Close of Common Stock Offering and Exercise of Underwriters' Overallotment OptionBusiness Wire |
| Thu, Nov 19 | Affymax plans to raise $69.6M in stock saleat bizjournals.com |
| Thu, Nov 19 | Affymax plans to offer 2.5M shares of stockAP |
| Thu, Nov 19 | Affymax Prices Public Offering of Common StockBusiness Wire |
| Wed, Nov 18 | Affymax Announces Proposed Public Offering of Common StockBusiness Wire |
| Tue, Nov 10 | Affymax Announces Completion of Final Scheduled Data Monitoring Committee Review of Phase 3 Hematide ProgramBusiness Wire |
| Sat, Nov 7 | AFFYMAX INC FinancialsEDGAR Online Financials |
| Thu, Nov 5 | AFFYMAX INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online |
| Thu, Nov 5 | New Star Analyst Rankings for Affymax, Inc.StarMine |
| Wed, Nov 4 | Affymax and Takeda Announce Hematide Publication in the New England Journal of MedicineBusiness Wire |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.